A model for the optimization of anti-inflammatory treatment with Chemerin
Routine treatment of mild to moderate pain with a combination of non-steroidal anti-inflammatory drugs such as paracetamol in combination with corticoid opioids can lead to severe complications including death from gastrointestinal injury or to drug dependence. There is a need for the development of...
Main Authors: | Laranjeira, S, Regan-Komito, D, Iqbal, A, Greaves, D, Payne, S, Orlowski, P |
---|---|
Format: | Journal article |
Published: |
Royal Society
2017
|
Similar Items
-
The role of chemerin and chemerin derived peptides in inflammation
by: Regan-Komito, D
Published: (2015) -
Murine Chemerin (T-20-S-156) enhances the resolution of inflammation in a murine model of zymosan induced peritonitis
by: Regan-Komito, D, et al.
Published: (2014) -
Absence of the non-signalling chemerin receptor CCRL2 exacerbates acute inflammatory responses in vivo
by: Regan-Komito, D, et al.
Published: (2017) -
THE CHIMERIC NATURE OF CHEMERIN IN THE SYMPHONY OF INFLAMMATION: ANTI-INFLAMMATORY EFFECTS OF CHEMERIN-DERIVED PEPTIDES
by: Greaves, D
Published: (2011) -
Absence of the Non-Signalling Chemerin Receptor CCRL2 Exacerbates Acute Inflammatory Responses In Vivo
by: Daniel Regan-Komito, et al.
Published: (2017-11-01)